AI-Driven Drug Formulation Developer

To strengthen academic exchange in the field of pharmaceutical formulations, promote the integration of industry, academia, and research in innovative formulation fields, and form a new pattern of fundamental theoretical breakthroughs driving key technological innovations, the Chinese Pharmaceutical Association hosts, and the Pharmaceutical Preparation Professional Committee of the Chinese Pharmaceutical Association...Undertaken by "The 17th Drug Formulation Conference"Proposed for"September 27-29, 2024InHangzhou, Zhejiang ProvinceConvene.
The theme of this year's conference is "The Integrated Development of the Formulation Innovation Chain and the Industrial Chain" as the theme, the conference will invite well-known experts from universities, scientific research institutes, pharmaceutical companies, R&D units, medical institutions, and management agencies in China to deliver keynote speeches and special presentations. The event will facilitate the exchange and discussion of new theories, technologies, products, and policy regulations in pharmaceutics, creating an efficient academic exchange platform to further promote communication and cooperation in the pharmaceutical formulation industry, contributing to the strategic goal of becoming a strong pharmaceutical power.

As a representative of a global leading "AI + drug delivery" company,Dr. Cai-Da Lai, Co-founder & CEO of METiS PharmaceuticalsInvited to attend this conference and will be present on the afternoon of September 29th (Sunday).Sub-venue 12: Roadshow on the Transformation of New Pharmaceutical Products and TechnologiesWith "AI-Driven Development of Multi-Organ Targeting LNP Delivery Materials"Delivered a keynote report titled, sharing the application practices of AI technology in the development of LNP delivery materials targeting multiple organs."
(METiS TechBio SpeechLink)
Related Reading:
Focus on "AI + Drug Delivery," METiS TechBio Completes $100 Million Series C Financing
